Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels.
about
Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directionsNovel biological markers of bone: from bone metabolism to bone physiologyAssociation of circulating sclerostin with vascular calcification in Afro-Caribbean men.Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.DKK1 rescues osteogenic differentiation of mesenchymal stem cells isolated from periodontal ligaments of patients with diabetes mellitus induced periodontitisHas sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?Independent association between serum sclerostin levels and carotid artery atherosclerosis in prevalent haemodialysis patients.Sclerostin serum levels in patients with systemic autoimmune diseasesSclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.Serum sclerostin in hepatitis C virus infected patients.Osteoprotegerin and sclerostin in chronic kidney disease prior to dialysis: potential partners in vascular calcifications.Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis.In Type-2 Diabetes Subjects Trabecular Bone Score is Better Associated with Carotid Intima-Media Thickness than BMD.Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy.Sclerostin, cardiovascular disease and mortality: a systematic review and meta-analysis.The Utility of Biomarkers in Osteoporosis Management.Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.Bone-Derived Factors: A New Gateway to Regulate Glycemia.Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4.Serum sclerostin values are associated with abdominal aortic calcification and predict cardiovascular events in patients with chronic kidney disease stages 3-5D.Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism and bone mineral density.Sclerostin in Obstructive Sleep Apnea.The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.Serum sclerostin in vascular calcification and clinical outcome in chronic kidney disease.Sclerostin Expression in Bile Ducts of Patients With Chronic Cholestasis May Influence the Bone Disease in Primary Biliary Cirrhosis.Circulating levels of sclerostin are associated with cardiovascular mortality.Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort
P2860
Q26750574-EB635BEF-E25A-44AC-8526-4A816F560CA2Q28067712-026455D4-388E-4493-A524-F0FF0647821EQ35091260-08DB6657-0075-4BA0-884E-03AEF7E3CBF3Q35861519-1633B8BA-7352-48E9-BEB3-7D34772799B9Q35960497-588FD633-B9D2-44C9-850F-34A1CAB3345FQ35967442-462117D0-92FF-4984-BEB4-C8B1228FF8A9Q36306725-769DDCAB-D8A4-41CB-B3C7-3E28256DFB5AQ36561360-5F1460B1-FD96-4FDC-856C-FB84CA8F45C1Q37428965-0BF26087-B609-4D33-92FB-A3B3FD6CDA80Q37673471-A5C8B107-56DD-4251-B2DD-5E45DC43352DQ38411782-CFB7BDB1-E572-4A82-8B35-B43F28DD2BB7Q38517043-D551003A-39BA-44E5-8121-8DA607D8CFE9Q38701082-2D237B51-8D81-4149-A194-5ABAA78C99CBQ38846381-77EC0B34-A346-419C-8663-E7D4ED6E5650Q38920636-9FDF7B0A-A573-44F7-95E0-92C381001E28Q38921875-D5CAADD6-C2AA-4C9F-9ED4-616132B13353Q38970563-8283BF6B-A412-4322-9AAD-569C95485423Q39004609-88374D01-B815-4181-8905-930C012790C9Q39342144-3BF4839F-2E1A-4061-8F86-369EE89E9F13Q39552618-7A7DF517-7616-483D-8909-B6282DF53C90Q40760789-A81275D2-9A57-464E-8EEE-E6CC07FAF791Q40815830-DBCF6563-6B6E-41E7-8D5D-531B5834B9A5Q40945270-63E22287-BBD4-4485-82F8-1699117FE54CQ44445878-60043E2E-DF34-4582-82E9-FD043070D86BQ49719211-DA346386-42A3-44E9-B262-AEE6AD2C4423Q53137198-64D40B99-08B6-411A-B626-578455F84FDDQ55496723-C27B25D4-00E1-4E8E-A1BB-6DDAD9BDB8F1Q57159790-1DDD0742-B6D2-4E05-BAE2-2BD8956D9ABA
P2860
Atherosclerotic disease in type 2 diabetes is associated with an increase in sclerostin levels.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Atherosclerotic disease in typ ...... increase in sclerostin levels.
@en
type
label
Atherosclerotic disease in typ ...... increase in sclerostin levels.
@en
prefLabel
Atherosclerotic disease in typ ...... increase in sclerostin levels.
@en
P2093
P2860
P356
P1433
P1476
Atherosclerotic disease in typ ...... increase in sclerostin levels.
@en
P2093
Antonia García-Martín
Beatriz García-Fontana
José Antonio García-Salcedo
Manuel Muñoz-Torres
Pedro Rozas-Moreno
Rebeca Reyes-García
Sonia Morales-Santana
P2860
P304
P356
10.2337/DC12-1691
P407
P577
2013-01-03T00:00:00Z